miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.

CONCLUSION: Our study suggested that miR-654-3p expression was downregulated in HCC and might serve as a potential prognostic marker and therapeutic target for the survival of HCC patients. miR-654-3p might exert a suppressor role in HCC through inhibiting tumor cell proliferation, migration, and invasion. PMID: 32176631 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32176631?dopt=Abstract

Source: Cancer Biomarkers - March 18, 2020 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research